BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Missouri State University/Calendar of Events//EN
CALSCALE:GREGORIAN
X-WR-TIMEZONE:America/Chicago
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
DTSTART:20070311T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
TZNAME:CDT
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
DTSTART:20071104T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
TZNAME:CST
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:4f4f2dad-21c4-4c1d-b5c8-756862efe2eb.234215@calendar.missouristate.edu
CREATED:20240206T171259Z
LAST-MODIFIED:20240206T171259Z
LOCATION:Meyer Library\, Duane G. 101
SUMMARY:Chemistry &amp; Biochemistry Seminar: "Modern Nanotechnologies for the
  Treatment of Cancer and Infectious Diseases"
DESCRIPTION:By: Dr. Santimukul Santra\, Missouri State University\n\n\n\n\
 n\nAbstract\n\n\nOur lab research focuses on investigating new nanotechno
 logies for helping society with cancer and infectious diseases. We develo
 p high throughput\, bioinspired nanoplatforms for delivering anticancer t
 herapeutics and antivirals\, while creating novel catalytic nanolabels fo
 r assessment of protective immunity of vaccination\; and point-of-care (P
 oC) technologies for the detection of infectious diseases. This presentat
 ion will introduce at our smart design for dendritic biomaterials and res
 ponsive nanoplatforms for targeted delivery for cancer therapeutics and f
 or the SARS-CoV-2 vaccine formulations. This vaccine delivery platform of
 fers unique features of carrying large protecting mRNA payloads and nucle
 i acids deliverables. In addition\, the unique catalytic nanosensors labe
 ls’ were integrated with lateral flow assay (LFA) technology for assessin
 g COVID-19 vaccine immunity that allows visualization of test results and
  for the detection of foodborne pathogens. The development of such modern
  nanotechnology platforms and their applications in biomedical research w
 ill be highlighted in this presentation. 
X-ALT-DESC;FMTTYPE=text/html:&lt;html&gt;&lt;head&gt;&lt;title&gt;&lt;/title&gt;&lt;/head&gt;&lt;body&gt;&lt;p&gt;&lt;b
 &gt;&lt;span&gt;By: Dr. Santimukul Santra\, Missouri State University&lt;/span&gt;&lt;/b&gt;&lt;/
 p&gt;\n&lt;p&gt;&lt;b&gt;&lt;span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;\n&lt;p&gt;&lt;b&gt;&lt;span&gt;Abstract&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;\n&lt;p&gt;
 &lt;span&gt;Our lab research focuses on investigating new nanotechnologies for 
 helping society with cancer and infectious diseases. We develop high thro
 ughput\, bioinspired nanoplatforms for delivering anticancer therapeutics
  and antivirals\, while creating novel catalytic nanolabels for assessmen
 t of protective immunity of vaccination\; and point-of-care (PoC) technol
 ogies for the detection of infectious diseases. This presentation will in
 troduce at our smart design for dendritic biomaterials and responsive nan
 oplatforms for targeted delivery for cancer therapeutics and for the SARS
 -CoV-2 vaccine formulations. This vaccine delivery platform offers unique
  features of carrying large protecting mRNA payloads and nuclei acids del
 iverables. In addition\, the unique catalytic nanosensors labels’ were in
 tegrated with lateral flow assay (LFA) technology for assessing COVID-19 
 vaccine immunity that allows visualization of test results and for the de
 tection of foodborne pathogens. The development of such modern nanotechno
 logy platforms and their applications in biomedical research will be high
 lighted in this presentation.&amp;nbsp\;&lt;/span&gt;&lt;span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/body&gt;&lt;/html&gt;
DTSTART;TZID=America/Chicago:20240214T153500
DTEND;TZID=America/Chicago:20240214T162500
SEQUENCE:0
URL:https://chemistry.missouristate.edu/Seminars.htm
CATEGORIES:Public,Alumni,Current Students,Faculty,Future Students,Staff
END:VEVENT
END:VCALENDAR